Paper42289752
Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer.
Nakao K and 7 others. Breast Cancer Res, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer. Papers, record 42289752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42289752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Breast Neoplasms | Major topic |
| Stromal Cells | Major topic |
| Tetraspanin 28 | Major topic |
| Humans | |
| Female | |
| Prognosis | |
| Middle Aged | |
| Cancer-Associated Fibroblasts | |
| Aged | |
| Biomarkers, Tumor | |
| Membrane Glycoproteins | |
| Adult | |
| Podoplanin | |
| Neoplasm Invasiveness | |
| Immunohistochemistry |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 23K06427 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35120598 | Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35120598 | PubMed |
| 2 | 38158643 | Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: "Single" vision for "heterogeneous" environment. | Cell Prolif | 2024 | https://conductscience.org/library/papers/38158643 | PubMed |
| 3 | 25071162 | Fibroblast heterogeneity in the cancer wound. | J Exp Med | 2014 | https://conductscience.org/library/papers/25071162 | PubMed |
| 4 | 31197017 | Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. | Cancer Discov | 2019 | https://conductscience.org/library/papers/31197017 | PubMed |
| 5 | 40724542 | Evaluation of Immunophenotypic Characteristics and Quantitative Differences of Telocytes Between Invasive Breast Cancer Subtypes. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40724542 | PubMed |
| 6 | 32573845 | Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32573845 | PubMed |
| 7 | 35020885 | Does CCL19 act as a double-edged sword in cancer development? | Clin Exp Immunol | 2022 | https://conductscience.org/library/papers/35020885 | PubMed |
| 8 | 36941633 | The versatile roles of testrapanins in cancer from intracellular signaling to cell-cell communication: cell membrane proteins without ligands. | Cell Biosci | 2023 | https://conductscience.org/library/papers/36941633 | PubMed |
| 9 | 36917949 | Activated fibroblasts in cancer: Perspectives and challenges. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36917949 | PubMed |
| 10 | 35883004 | Cancer-associated fibroblasts in the single-cell era. | Nat Cancer | 2022 | https://conductscience.org/library/papers/35883004 | PubMed |
| 11 | 23162750 | High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes. | Oncoimmunology | 2012 | https://conductscience.org/library/papers/23162750 | PubMed |
| 12 | 26329536 | Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells. | Cancer Res | 2015 | https://conductscience.org/library/papers/26329536 | PubMed |
| 13 | 39723208 | Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features. | Front Immunol | 2024 | https://conductscience.org/library/papers/39723208 | PubMed |
| 14 | 37061568 | Telocytes and ezrin expression in normal-appearing tissues adjacent to urothelial bladder carcinoma as predictors of invasiveness and recurrence. | Sci Rep | 2023 | https://conductscience.org/library/papers/37061568 | PubMed |
| 15 | 36585155 | CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells. | Anticancer Res | 2023 | https://conductscience.org/library/papers/36585155 | PubMed |
| 16 | 30514914 | Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. | Nat Commun | 2018 | https://conductscience.org/library/papers/30514914 | PubMed |
| 17 | 37401015 | High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma. | Cell Prolif | 2023 | https://conductscience.org/library/papers/37401015 | PubMed |
| 18 | 30117494 | Increased Expression of CD81 in Breast Cancer Tissue is Associated with Reduced Patient Prognosis and Increased Cell Migration and Proliferation in MDA-MB-231 and MDA-MB-435S Human Breast Cancer Cell Lines In Vitro. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30117494 | PubMed |
| 19 | 39566495 | Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer. | Cell | 2025 | https://conductscience.org/library/papers/39566495 | PubMed |
| 20 | 24733393 | The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24733393 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42698831 | Cyclin-dependent kinase 4 and 6 inhibitors and the breast cancer immune ecosystem: immune remodeling, resistance, and therapeutic reprogramming. | Front Immunol | 2026 | https://conductscience.org/library/papers/42698831 |
Source PubMed
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL19 | 6363 | PubTator's text mining | https://conductscience.org/library/genes/6363 | NCBI Gene |
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| CD81 | 975 | PubTator's text mining | https://conductscience.org/library/genes/975 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| FAP | 2191 | PubTator's text mining | https://conductscience.org/library/genes/2191 | NCBI Gene |
| PDGFRA | 5156 | PubTator's text mining | https://conductscience.org/library/genes/5156 | NCBI Gene |
| PDPN | 10630 | PubTator's text mining | https://conductscience.org/library/genes/10630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42289752
GET https://conductscience.org/api/papers/v1/42289752/references?page=2